President Trump is turning up pressure on drugmakers to lower prices and demanding they commit within weeks to his "most-favored nation" policy, Commerce Secretary Howard Lutnick tells Mike Allen in ...

Lutnick added that Trump believes forcing the EU and other nations to pay more would reduce the burden on American consumers.

GlaxoSmithKline hasn’t made plans to pursue an initial public offering on the consumer health company it created with Pfizer, a top executive told Bloomberg a day after Pfizer’s CEO said they plan to ...

A small developer of vaccines passed a milestone last week on the long road to a preventive shot for Lyme disease. The French ...

Sixteen plaintiffs' allegations against Big Pharma stand after a judge denied the companies' motion to dismiss. The plaintiffs claim that they developed cancer due to the medication Zantac, which is ...

The Metastatic Non-Small Cell Lung Cancer market size was valued ~21 billion in 2023 and is anticipated to grow with a ...

If your investing decisions were based solely on past performance, Pfizer Inc. (NYSE: PFE) would be the better stock to buy than GlaxoSmithKline plc (NYSE: GSK). Over the past 12 months, three years, ...